Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:affects |
plasma cells
|
| gptkbp:common_test |
imaging studies
complete blood count serum protein electrophoresis urine protein electrophoresis |
| gptkbp:complication |
infections
renal failure bone fractures hypercalcemia |
| gptkbp:condition |
gptkb:Amyloidosis
gptkb:MGUS Waldenström macroglobulinemia |
| gptkbp:diagnosis |
blood tests
varies by individual bone marrow biopsy |
| https://www.w3.org/2000/01/rdf-schema#label |
Multiple Myeloma
|
| gptkbp:number_of_stages |
gptkb:active_multiple_myeloma
gptkb:refractory_multiple_myeloma gptkb:smoldering_multiple_myeloma relapsed multiple myeloma |
| gptkbp:prevalence |
more common in men than women
higher incidence in African Americans approximately 1% of all cancers |
| gptkbp:research_areas |
clinical trials
genetic studies new drug development |
| gptkbp:risk_factor |
age
obesity family history exposure to radiation |
| gptkbp:side_effect |
fatigue
nausea hair loss increased risk of infection |
| gptkbp:symptoms |
gptkb:anemia
fatigue bone pain kidney dysfunction increased infections |
| gptkbp:treatment |
gptkb:immunotherapy
chemotherapy targeted therapy symptom management remission stem cell transplant prolonging survival |
| gptkbp:type_of_care |
nutritional support
physical therapy psychosocial support pain management |
| gptkbp:bfsParent |
gptkb:Dr._Paul_Richardson
|
| gptkbp:bfsLayer |
6
|